Status:
COMPLETED
Sigmoid Take-off, New Rectum Definition
Lead Sponsor:
Peking University Third Hospital
Conditions:
Rectal Cancer
Eligibility:
All Genders
Brief Summary
The diversity of definitions for the rectosigmoid junction is becoming a major obstacle to the standardization of optimal treatment of rectal cancers. The aim of this study was to determine the averag...
Detailed Description
Method Patients All patients pathologically diagnosed with sigmoid or rectal cancer in Peking University Third Hospital from January 2010 to December 2018 were included in our study as the cancer grou...
Eligibility Criteria
Inclusion
- \- All patients pathologically diagnosed with sigmoid or rectal cancer in Peking University Third Hospital from January 2010 to December 2018 were included in our study as the cancer group. Patients who were found on endoscopy to have cancer more than 20 cm from the anal verge were not included. Patients who received emergency surgery or palliative surgery, patients with a previous history of pelvic surgery, and patients without extractable radiological examinations were also excluded.
Exclusion
- Patients who were found on endoscopy to have cancer more than 20 cm from the anal verge were not included.
- Patients who received emergency surgery or palliative surgery, patients with a previous history of pelvic surgery, and patients without extractable radiological examinations were also excluded.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
835 Patients enrolled
Trial Details
Trial ID
NCT04293835
Start Date
June 1 2019
End Date
February 1 2020
Last Update
March 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Surgery Department, Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191